Last updated 30 days ago

A Study Evaluating Different Immunotherapies (LAG-3 and PD-1 With or Without TIGIT, Compared to PD-L1 Alone) in Participants With Untreated Locally Advanced Metastatic Urothelial Cancer

240 patients around the world
Available in Spain, United States, Brazil
Hoffmann-La Roche
5Research sites
240Patients around the world
This study is for people with
Bladder Cancer
Requirements for the patient
From 18 Years
All Gender
Medical requirements
Sites
Hospital de Amor Amazônia
Recruiting
BR-364, 15 - Porto Velho, RO, Brazil
Centro de Estudos e Pesquisas de Hematologia e Oncologia - CEPHO
Recruiting
Av. Príncipe de Gales, 821 - Vila Principe de Gales, Santo André - SP, 09060-650
Hospital Alemão Oswaldo Cruz
Recruiting
R. Treze de Maio, 1815 - Bela Vista, São Paulo - SP, 01323-020, Brazil
Health Pharma Professional Research
Dakota 351, Nápoles, Benito Juárez, 03840 Ciudad de México, CDMX, Mexico
Hospital Clínico San Carlos
Recruiting
Profesor Martín Lagos, s/n 28040 Madrid
Trialtech
About usOur missionOur teamPartnersFAQs
Medical newsLatest newsStudiesInterviewsTestimonials
ProductsUEPM OncoUEPM Physicians
LinksDownloads
LinkedinInstagramFacebook
Terms and ConditionsPrivacy Policy